HT
HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $221.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
0 /100
Declining Rev. growth 30.79%
Book val. growth 39.18%
EPS growth N/A
Profitability
10 /100
Weak Gross margin 28.18%
FCF margin 289.51%
Net margin 339.20%
Quality
6 /100
Poor ROIC 151.08%
Asset turnover 0.36x
ROA 121.47%
Debt
59 /100
Moderate Debt/Equity 1.55x
Net debt/EBITDA 0.19x
Current ratio 1.89x
Stability
40 /100
Moderate Beta 2.96x
Profitable years 0
Rev. volatility 29.88%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HTGMQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John L. Lubniewski
Employees
53
Headquarters
Tucson
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report